We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
(-6.1%)
Cap. Flow
-$1.56B
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$352M |
| 2 |
Kroger
KR
|
+$279M |
| 3 |
AT&T
T
|
+$235M |
| 4 |
Intel
INTC
|
+$217M |
| 5 |
Edwards Lifesciences
EW
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Merck
MRK
|
+$459M |
| 3 |
Coca-Cola
KO
|
+$295M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$283M |
| 5 |
TSMC
TSM
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.08% |
| 2 | Technology | 16.14% |
| 3 | Healthcare | 15.45% |
| 4 | Consumer Discretionary | 9.74% |
| 5 | Consumer Staples | 5.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Expedia Group
EXPE
$31.2B
| $29.6M | 0.06% |
316,032
-938,964
| -75% | -$95.8M |
|
327
Tidewater
TDW
$3.91B
| $29.4M | 0.06% |
+1,356,562
| New | +$28.9M |
|
328
Revolve Group
RVLV
$1.79B
| $29.4M | 0.06% |
1,355,566
-506,533
| -27% | -$13.3M |
|
329
Martin Marietta Materials
MLM
$33.6B
| $29.1M | 0.06% |
90,364
-64,137
| -42% | -$21.7M |
|
|
JWN
330
DELISTED
Nordstrom
JWN
| $29.1M | 0.06% |
1,738,578
-3,737,044
| -68% | -$78M |
|
331
Atlassian
TEAM
$22B
| $29M | 0.06% |
137,640
+119,283
| +650% | +$27.9M |
|
|
HIII
332
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
| $29M | 0.06% |
2,939,308
+356,990
| +14% | +$3.51M |
|
333
Starwood Property Trust
STWD
$6.12B
| $28.8M | 0.06% |
1,582,707
-160,071
| -9% | -$3.63M |
|
334
Peabody Energy
BTU
$2.78B
| $28.7M | 0.06% |
1,158,121
+860,517
| +289% | +$19.3M |
|
335
PUT
iShares China Large-Cap ETF
FXI
$4.31B
| $28.6M | 0.06% |
1,105,100
+708,100
| +178% | +$21.2M |
|
336
SLM Corp
SLM
$4.57B
| $28.5M | 0.06% |
+2,036,440
| New | +$31.6M |
|
337
Dollar Tree
DLTR
$23.1B
| $28.3M | 0.06% |
207,761
+130,342
| +168% | +$20.3M |
|
338
PUT
Apple
AAPL
$4.89T
| $28.1M | 0.06% |
203,600
+6,200
| +3% | +$973K |
|
|
EOCW
339
DELISTED
Elliott Opportunity II Corp.
EOCW
| $28.1M | 0.06% |
2,857,509
| – | – |
|
|
SLAM
340
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $27.9M | 0.06% |
2,813,848
| – | – |
|
341
Ares Capital
ARCC
$13.5B
| $27.9M | 0.06% |
1,652,008
-1,195,143
| -42% | -$23.1M |
|
342
West Pharmaceutical
WST
$23.1B
| $27.8M | 0.06% |
113,177
+87,634
| +343% | +$26.7M |
|
|
343
PUT
Intel
INTC
$466B
| $27.8M | 0.06% |
1,080,100
+957,300
| +780% | +$32.6M |
|
|
CHS
344
DELISTED
Chicos FAS, Inc.
CHS
| $27.8M | 0.06% |
5,738,808
-163,064
| -3% | -$906K |
|
345
CALL
Netflix
NFLX
$292B
| $27.7M | 0.06% |
1,176,000
-4,010,000
| -77% | -$89.1M |
|
|
SCOA
346
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $27.5M | 0.06% |
2,762,457
| – | – |
|
347
Keysight
KEYS
$54.5B
| $27.3M | 0.06% |
173,293
-57,667
| -25% | -$9.23M |
|
348
Ciena
CIEN
$55.3B
| $27.3M | 0.06% |
674,031
+205,808
| +44% | +$9.89M |
|
|
LGAC
349
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $27.2M | 0.06% |
2,742,530
+50,365
| +2% | +$497K |
|
|
SVFA
350
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
| $27.1M | 0.06% |
2,722,746
| – | – |
|
Similar funds
Marshall Wace's Q3 2022 Portfolio in Review
As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.
- Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
- Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
- Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
- Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
- Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
- Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
- Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.
Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.